Biotech · Private company
Immunitas Therapeutics
Track this companyFree. Adds Immunitas Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- FruquintinibPhase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- IMT-009Phase 2 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or LymphomasPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Nov 28, 2022ClinicalTrials.gov NCT05565417 · fetched Nov 12, 2026